← Back to headlines
Moderna Stock Surges on Hantavirus Vaccine News
Moderna's shares saw a significant rise in the stock market following the announcement of its preclinical work to develop a hantavirus vaccine in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
